Moran Sean F.

Chief Financial OfficerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$864K
Net Open-Market Flow
-$864K
Transactions
12
8 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2024Option exercise(M)2K$30.00$59K51K
Jun 18, 2024Sell(S)2K$42.12$82K49K
Jun 17, 2024Sell(S)7K$46.77$315K49K
Jun 17, 2024Option exercise(M)7K$14.10$95K55K
Jun 14, 2024Option exercise(M)2K$30.00$47K50K
Jun 14, 2024Sell(S)8K$49.87$388K49K
Jun 14, 2024Sell(S)2K$49.87$78K49K
Jun 14, 2024Option exercise(M)8K$4.26$33K56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2024Option exercise(M)2K$00
Jun 17, 2024Option exercise(M)7K$011K
Jun 14, 2024Option exercise(M)8K$023K
Jun 14, 2024Option exercise(M)2K$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-075075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CRBP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-075075"
Ask your agent
Use Arkolith to summarize insider buying and selling at Corbus Pharmaceuticals Holdings, Inc.
over the last 90 days and cite the filings.